Acompila (Rimonabant) - the assistant in weight reduction

Preparation ACOMPLIA of 20 mg is intended for depression plural metabolic risk factors at patients with adiposity and excess weight. Among patients whom the preparation will arise exceptionally good, - patients with abdominal adiposity (the ample circle of a waist), suffering again diabetes. Nearly half of man population having the enlarged circle of a waist (added than 102 sm or 40 inches at men and 88 sm or 35 inches at women), accept not less than 3 supplementary risk factors, all from which lift risk metabolic disturbances.
"Till immediately we didn't accept a medical product for access on plural metabolic risk factors which lift probability of process of cardiovascular diseases and diabetes of 2nd type" the Dr. of medicine Ljuk Car Gaal, the professor diabetology, a metabolism and clinical dietology from hospital of Antwerp university (Belgium), the principal of analysis RIO Europe has told. "Acomplia (Rimonabant) an valuable process forward to treatment of the plural risk factors which locate causes risk of diabetes and cardiovascular diseases. This preparation has service over existing ways of treatment of seperate risk factors, for archetype, the raised arterial force, cholesterol and diabetes"
The common metabolic the risk is the sum of risks of process of a diabetes of 2nd type and-or cardiovascular diseases; it represents a combination of risk factors which it is imaginable to access. To figure metabolic risk factors, for archetype, aerial akin of cholesterol, a hypertonia and a hyperglycemia, and again the fresh risk factors closely bound to abdominal adiposity, for archetype, resistence classical risk factors care insulin, low akin of cholesterol, aerial akin of triglycerides, and again inflammation markers: the S-jet protein.